查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2048074

維生素B2市場－全球產業規模、佔有率、趨勢、機會、預測：銷售管道、最終用途、地區和競爭格局（2021-2031年）

Vitamin B2 Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel, By End Use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球維生素 B2 市場預計將從 2025 年的 5.1303 億美元成長到 2031 年的 6.6695 億美元，複合年成長率為 4.47%。

核黃素是一種必需的水溶性微量營養素，對能量代謝、細胞過程以及其他維生素的合成至關重要。該市場的成長主要受動物營養領域需求成長的驅動，核黃素在動物營養領域是一種重要的飼料添加劑，對牲畜的健康和生長至關重要。此外，消費者對健康保健日益成長的關注也推動了營養補充品和強化食品的需求。除了這些基本因素外，生物發酵生產方法和消費者對潔淨標示成分的偏好等新興趨勢也在推動市場的發展。

市場概覽
預測期 2027-2031
市場規模：2025年 5.1303億美元
市場規模：2031年 6.6695億美元
複合年成長率：2026-2031年 4.47%
成長最快的細分市場 直接的
最大的市場 北美洲

然而，該市場面臨許多障礙，主要原因是生產能力集中在特定地區。這種地域依賴性導致供應鏈存在顯著的脆弱性，一旦監管政策改變或物流中斷，往往會導致價格波動。中國醫藥保健品進出口商會報告的數據顯示，2024年3月中國維生素B2出口額約為1,100萬美元，凸顯了主要生產基地在全球供應中發揮的關鍵作用，也印證了這種生產主導地位。

市場促進因素

鑑於核黃素作為牲畜代謝和高效生長必需微量營養素的關鍵作用，強化飼料添加劑日益成長的需求是推動市場擴張的主要動力。在現代工業化養殖中，尤其是在家禽和生豬養殖領域，精準補充維生素B2至關重要，有助於預防營養缺乏症並最佳化飼料轉換率。這種對強化添加劑的強烈依賴與全球飼料產業的穩定擴張直接相關，而飼料產業旨在滿足蛋白質消費需求。根據Alltek於2025年4月發布的《2025年農業食品展望》，預計2024年全球飼料產量將成長1.2%，達到13.96億噸，證實了工業界對核黃素的強勁需求。

同時，機能性食品和飲料產業的成長也是一股強勁的次要驅動力，這主要得益於消費者對能量代謝和健康保健意識的不斷提高。隨著人們越來越重視整體健康，製造商也意識到維生素B2對細胞能量產生的貢獻，並透過在運動營養食品和強化零食中添加維生素B2來拓展產品系列。 2025年2月，《全食雜誌》（WholeFoods Magazine）根據CRN 2024年的消費者調查報告稱，消費者對運動營養產品（B族維生素強化的一個關鍵領域）的接受度在2024年達到了45%。這種持續的終端用戶需求有助於穩定市場，抵禦供應鏈波動的影響，凸顯了這個原料消費領域的龐大規模。根據dsm-firmenich公司2024年綜合年度報告顯示，光是dsm-firmenich的「動物營養與健康」部門在2024年的累計就超過了33億歐元。

市場挑戰

全球維生素B2市場面臨許多挑戰，其中最主要的障礙在於生產能力高度集中在單一地理區域，這本身就造成了供應鏈的嚴重脆弱性。這種生產集中化造成了瓶頸，不可避免地將全球供應與少數幾家主要生產商的營運穩定性掛鉤。因此，這些關鍵製造地的當地監管變化、能源短缺或物流中斷都可能立即引發全球供不應求和價格劇烈波動。此類不確定性使得動物營養和製藥業的國際買家難以製定長期籌資策略。他們往往難以獲得價格穩定且持續的供應契約，這限制了整體市場的穩定和擴張。

近期貿易數據清晰地顯示了這種地域依賴的嚴重性，凸顯了主要生產基地規模的巨大優勢。例如，根據中國醫藥保健品進出口商會預測，受維生素生產影響較大的西方醫藥原料出口額，預計2025年第一季將達到111億美元。這種對單一供應區域的過度依賴迫使全球相關人員承擔高額風險溢價，並應對庫存水準的波動，直接阻礙了市場的穩定成長。

市場趨勢

植物來源乳製品替代品的營養強化是一個重要的趨勢，目前有一種趨勢是有意在非乳類飲料中添加核黃素，以模擬傳統牛奶的營養成分。隨著消費者擴大選擇燕麥、杏仁和大豆等替代品而非傳統乳製品，製造商不得不解決這些植物來源原料中固有的維生素B2缺乏問題，以保持產品的競爭力和營養價值。這種特定的應用需求與植物來源產業的商業性擴張直接相關，各大品牌越來越注重宣傳“全面營養”，以吸引和留住注重健康的消費者。根據良好食品研究所（Good Food Institute）於2025年4月發布的《2024年產業趨勢》報告，2024年全球植物來源肉品和乳製品替代品的零售額將達到286億美元，這為這些加工產品中核黃素強化提供了強勁且不斷成長的基礎需求。

另一項變革性趨勢是微膠囊化技術的應用。這項技術透過有效解決將核黃素添加到機能性食品和高級膳食補充劑中固有的穩定性和口感問題，正在重新定義市場。這項創新加工技術能夠保護維生素免受氧化和劣化，同時掩蓋其天然苦味，使其能夠製成比傳統片劑更廣泛的劑型。此外，先進的膠囊化技術目前正被用於精確控制釋放曲線，以實現特定的健康益處，例如支持腸道菌叢。作為這項技術進步的例證，帝斯曼-菲美尼奇於2025年2月發布的2024年度綜合報告重點介紹了採用專有膠囊化技術的新型生物活性維生素解決方案的推出。此解決方案可將90%的核黃素直接輸送到大腸，與遊離形式相比，顯著提高了其生物有效性。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球維生素B2市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 銷售管道（直接、間接）
    • 依應用領域（飼料、藥品/補充劑、食品/飲料添加劑、色素、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美維生素B2市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲維生素B2市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區維生素B2市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲維生素B2市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美維生素B2市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球維生素B2市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Hubei Guangji Pharmaceutical Co., Ltd
  • dsm-firmenich
  • BASF SE
  • Haijianuo Pharmaceutical Co., Ltd.
  • Zhejiang Shengda Bio-Pharm Co Ltd.
  • Shandong Hongda Biological Technology Co., Ltd.
  • Xinfa Pharmaceutical Co. Ltd
  • NB Group Co. Ltd

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 29219

The Global Vitamin B2 Market is forecasted to expand from USD 513.03 Million in 2025 to USD 666.95 Million by 2031, achieving a Compound Annual Growth Rate (CAGR) of 4.47%. Riboflavin, a vital water-soluble micronutrient, is crucial for energy metabolism, cellular processes, and the creation of other vitamins. This market's growth is primarily fueled by the increasing demand in the animal nutrition sector, where it serves as an indispensable feed additive for livestock health and development. Furthermore, heightened consumer interest in preventative healthcare is boosting the demand for dietary supplements and fortified food items. These foundational elements drive the market, separate from evolving trends such as the preference for biological fermentation production methods and clean label ingredients.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 513.03 Million
Market Size 2031USD 666.95 Million
CAGR 2026-20314.47%
Fastest Growing SegmentDirect
Largest MarketNorth America

Nevertheless, the market faces considerable hurdles, largely stemming from the high concentration of manufacturing capabilities within specific regions. This geographical dependency creates significant supply chain vulnerabilities, often resulting in price instability when regulatory changes or logistical disruptions occur. This manufacturing dominance is underscored by figures like the approximately USD 11 million in Vitamin B2 exports from China in March 2024, as reported by the China Chamber of Commerce for Import and Export of Medicines and Health Products, emphasizing the critical role major production hubs play in maintaining global supply.

Market Driver

The escalating need for fortified animal feed additives acts as the primary catalyst for market expansion, given riboflavin's fundamental role as a micronutrient vital for livestock metabolism and efficient growth. Modern industrial agricultural practices, particularly within the poultry and swine industries, necessitate precise Vitamin B2 supplementation to prevent deficiency-related disorders and optimize feed conversion ratios. This intense reliance on fortified additives correlates directly with the steady expansion of the global feed industry, which aims to satisfy protein consumption requirements. According to Alltech's '2025 Agri-Food Outlook' in April 2025, global feed production volumes increased by 1.2% to 1.396 billion metric tons in 2024, confirming the consistent industrial demand for riboflavin.

Concurrently, the growth of the functional food and beverage sector serves as a robust secondary driver, propelled by heightened consumer awareness regarding energy metabolism and preventative healthcare. As individuals increasingly prioritize overall wellness, manufacturers are broadening their product portfolios to incorporate Vitamin B2 into sports nutrition and fortified snacks, recognizing its contribution to cellular energy production. WholeFoods Magazine reported in February 2025, based on CRN's 2024 Consumer Survey, that consumer usage of sports nutrition products-a key area for B-complex fortifications-climbed to 45% in 2024. This sustained end-user demand helps stabilize the market against broader supply chain fluctuations, with dsm-firmenich's Animal Nutrition & Health division alone generating over €3.3 billion in annual revenues in 2024, as noted in their Integrated Annual Report 2024, highlighting the financial scale of this ingredient-consuming sector.

Market Challenge

The Global Vitamin B2 Market faces substantial impediments due to the severe concentration of its manufacturing capacity within a single geographic region, which inherently creates acute vulnerabilities in the supply chain. This centralized production acts as a bottleneck, linking global availability inextricably to the operational stability of a limited number of major producers. Consequently, any local regulatory shifts, energy scarcities, or logistical interruptions in this primary manufacturing hub can swiftly trigger global shortages and sharp price volatility. Such uncertainty complicates the long-term procurement strategies for international buyers in the animal nutrition and pharmaceutical sectors, who frequently struggle to secure consistent supply contracts at stable rates, thereby restricting overall market stability and expansion.

The profound extent of this geographic reliance is clearly demonstrated by recent trade performance data, which highlights the sheer scale of the dominant production hub. For example, according to the China Chamber of Commerce for Import and Export of Medicines and Health Products, the export value of Western medicine raw materials-a sector heavily influenced by vitamin production-reached USD 11.1 billion in the first quarter of 2025. This heavy dependence on a solitary source region compels global stakeholders to absorb elevated risk premiums and manage fluctuating inventory levels, directly impeding consistent market growth.

Market Trends

The fortification of plant-based dairy alternatives represents a significant trend, involving the deliberate addition of riboflavin to non-dairy beverages to emulate the nutritional composition of traditional bovine milk. As consumers increasingly opt for substitutes like oat, almond, and soy varieties over conventional dairy, manufacturers are prompted to address the inherent deficiency of Vitamin B2 in these plant-derived sources to maintain product competitiveness and nutritional equivalence. This specific application demand is directly proportional to the commercial expansion of the plant-based sector, with brands increasingly emphasizing "complete nutrition" claims to attract and retain health-conscious consumers. The Good Food Institute's '2024 State of the Industry' report from April 2025 indicates that global retail sales of plant-based meat and dairy alternatives ascended to USD 28.6 billion in 2024, establishing a substantial and growing foundational requirement for riboflavin fortification in these formulated products.

Another transformative trend is the adoption of microencapsulation technologies, which are redefining the market by effectively addressing the intrinsic stability and taste issues associated with incorporating riboflavin into functional foods and advanced supplements. This innovative processing technique shields the vitamin from oxidation and light degradation while concurrently masking its naturally bitter flavor, thereby enabling its inclusion in a broader spectrum of delivery formats beyond conventional tablets. Furthermore, sophisticated encapsulation methods are now being utilized to manage precise release profiles for targeted health benefits, such as supporting the gut microbiome. Illustrating this technological progress, dsm-firmenich's 'Integrated Annual Report 2024' from February 2025 highlighted the launch of a new biotic vitamin solution that employs proprietary encapsulation to deliver 90% of the riboflavin directly to the colon, significantly improving its bioavailability compared to free forms.

Key Market Players

  • Hubei Guangji Pharmaceutical Co., Ltd
  • dsm-firmenich
  • BASF SE
  • Haijianuo Pharmaceutical Co., Ltd.
  • Zhejiang Shengda Bio-Pharm Co Ltd.
  • Shandong Hongda Biological Technology Co., Ltd.
  • Xinfa Pharmaceutical Co. Ltd
  • N.B Group Co. Ltd

Report Scope

In this report, the Global Vitamin B2 Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Vitamin B2 Market, By Sales Channel

  • Direct
  • Indirect

Vitamin B2 Market, By End Use

  • Animal feed
  • Pharmaceuticals & Supplements
  • Food & Beverage Fortification
  • Colorant
  • Others

Vitamin B2 Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Vitamin B2 Market.

Available Customizations:

Global Vitamin B2 Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Vitamin B2 Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Sales Channel (Direct, Indirect)
    • 5.2.2. By End Use (Animal feed, Pharmaceuticals & Supplements, Food & Beverage Fortification, Colorant, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Vitamin B2 Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Sales Channel
    • 6.2.2. By End Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Vitamin B2 Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Sales Channel
        • 6.3.1.2.2. By End Use
    • 6.3.2. Canada Vitamin B2 Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Sales Channel
        • 6.3.2.2.2. By End Use
    • 6.3.3. Mexico Vitamin B2 Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Sales Channel
        • 6.3.3.2.2. By End Use

7. Europe Vitamin B2 Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Sales Channel
    • 7.2.2. By End Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Vitamin B2 Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Sales Channel
        • 7.3.1.2.2. By End Use
    • 7.3.2. France Vitamin B2 Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Sales Channel
        • 7.3.2.2.2. By End Use
    • 7.3.3. United Kingdom Vitamin B2 Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Sales Channel
        • 7.3.3.2.2. By End Use
    • 7.3.4. Italy Vitamin B2 Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Sales Channel
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain Vitamin B2 Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Sales Channel
        • 7.3.5.2.2. By End Use

8. Asia Pacific Vitamin B2 Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Sales Channel
    • 8.2.2. By End Use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Vitamin B2 Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Sales Channel
        • 8.3.1.2.2. By End Use
    • 8.3.2. India Vitamin B2 Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Sales Channel
        • 8.3.2.2.2. By End Use
    • 8.3.3. Japan Vitamin B2 Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Sales Channel
        • 8.3.3.2.2. By End Use
    • 8.3.4. South Korea Vitamin B2 Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Sales Channel
        • 8.3.4.2.2. By End Use
    • 8.3.5. Australia Vitamin B2 Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Sales Channel
        • 8.3.5.2.2. By End Use

9. Middle East & Africa Vitamin B2 Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Sales Channel
    • 9.2.2. By End Use
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Vitamin B2 Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Sales Channel
        • 9.3.1.2.2. By End Use
    • 9.3.2. UAE Vitamin B2 Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Sales Channel
        • 9.3.2.2.2. By End Use
    • 9.3.3. South Africa Vitamin B2 Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Sales Channel
        • 9.3.3.2.2. By End Use

10. South America Vitamin B2 Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Sales Channel
    • 10.2.2. By End Use
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Vitamin B2 Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Sales Channel
        • 10.3.1.2.2. By End Use
    • 10.3.2. Colombia Vitamin B2 Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Sales Channel
        • 10.3.2.2.2. By End Use
    • 10.3.3. Argentina Vitamin B2 Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Sales Channel
        • 10.3.3.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Vitamin B2 Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Hubei Guangji Pharmaceutical Co., Ltd
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. dsm-firmenich
  • 15.3. BASF SE
  • 15.4. Haijianuo Pharmaceutical Co., Ltd.
  • 15.5. Zhejiang Shengda Bio-Pharm Co Ltd.
  • 15.6. Shandong Hongda Biological Technology Co., Ltd.
  • 15.7. Xinfa Pharmaceutical Co. Ltd
  • 15.8. N.B Group Co. Ltd

16. Strategic Recommendations

17. About Us & Disclaimer